Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histamine release via immune system stimulation refers to the rapid liberation of histamine from mast cells and basophils in response to immune stimuli, primarily allergen-IgE interactions. This process triggers a cascade of events leading to vasodilation, increased vascular permeability, smooth muscle contraction, and inflammation, contributing to various allergic and inflammatory diseases. While not a direct therapeutic target itself, understanding and modulating this process is crucial for managing hypersensitivity disorders.
N/A - This is a process, not a target.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histamine Release via Immune System Stimulation.